HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Matthias Lüftl Selected Research
Matthias Lüftl Research Topics
Disease
3
Neoplasms (Cancer)
02/2012 - 08/2004
2
Neoplasm Metastasis (Metastasis)
01/2005 - 08/2004
2
Melanoma (Melanoma, Malignant)
01/2005 - 08/2004
1
Measles
06/2019
1
Mumps
06/2019
1
Warts (Wart)
06/2019
1
Rubella (German Measles)
06/2019
1
Paraproteinemias (Monoclonal Gammopathy)
12/2010
1
Skin Manifestations
12/2010
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2010
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2005
1
Acquired Immunodeficiency Syndrome (AIDS)
11/2005
1
Disease Progression
08/2004
Drug/Important Bio-Agent (IBA)
2
Neoplasm Antigens (Tumor Antigens)
IBA
01/2005 - 08/2004
1
Measles-Mumps-Rubella Vaccine (MMR Vaccine)
IBA
06/2019
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
02/2012
1
Essential Amino Acids
IBA
02/2012
1
Enzymes
IBA
02/2012
1
Tryptophan (L-Tryptophan)
FDA Link
02/2012
1
Immunoglobulin M (IgM)
IBA
12/2010
1
Monoclonal Antibodies
IBA
11/2005
1
Rituximab (Mabthera)
FDA Link
11/2005
1
Messenger RNA (mRNA)
IBA
01/2005
1
Histocompatibility Antigens Class I
IBA
08/2004
1
Peptides (Polypeptides)
IBA
08/2004
Therapy/Procedure
2
Immunotherapy
06/2019 - 01/2005
1
Therapeutics
08/2004